Literature DB >> 7782640

Flow cytometric analysis of nuclear DNA content in oral leukoplakia: relation to clinicopathologic findings.

T Saito1, T Yamashita, K Notani, H Fukuda, S Mizuno, M Shindoh, A Amemiya.   

Abstract

DNA ploidy of 50 biopsy specimens of oral leukoplakia was investigated by flow cytometry, and the results were compared with the clinicopathologic appearances. The aneuploidy rate of the leukoplakias was 17/50 (34%), and the mean DNA index (DI) of the aneuploid lesions was 1.22, with a range from 0.70 to 1.84. The incidence of the aneuploidy was significantly (P < 0.01) higher in nonhomogeneous leukoplakias (11/18) than in homogeneous lesions (6/32). The aneuploidy rate of the severely dysplastic leukoplakias (11/17) was significantly higher than those of the mildly dysplastic (4/22; P < 0.01) and the nondysplastic (2/11; P < 0.02) lesions. A significant (P < 0.01) difference in the aneuploidy rate was also observed between tongue (12/23) and gingival (2/18) leukoplakias.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7782640     DOI: 10.1016/s0901-5027(05)80855-0

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  3 in total

1.  Correlation between histological grading and ploidy status in potentially malignant disorders of the oral mucosa: A flow cytometric analysis.

Authors:  T Vijayavel; N Aswath
Journal:  J Oral Maxillofac Pathol       Date:  2013-05

2.  Genomic DNA Copy Number Aberrations, Histological Diagnosis, Oral Subsite and Aneuploidy in OPMDs/OSCCs.

Authors:  Patrizio Castagnola; Gabriele Zoppoli; Sergio Gandolfo; Massimiliano Monticone; Davide Malacarne; Gabriella Cirmena; David Brown; Cinzia Aiello; Massimo Maffei; Roberto Marino; Walter Giaretti; Monica Pentenero
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

3.  Predicting malignant progression in clinically high-risk lesions by DNA ploidy analysis and dysplasia grading.

Authors:  Zuraiza Mohamad Zaini; Helen McParland; Henrik Møller; Kate Husband; Edward W Odell
Journal:  Sci Rep       Date:  2018-10-26       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.